GenMark Diagnostics, Inc. 4
4 · GenMark Diagnostics, Inc. · Filed Jan 25, 2016
Insider Transaction Report
Form 4
Chakravarty Ingo
SVP, International
Transactions
- Exercise/Conversion
Market Stock Units
2016-01-21−508→ 16,172 totalExercise: $0.00→ Common Stock (508 underlying) - Sale
Common Stock
2016-01-21$6.80/sh−227$1,544→ 62,159 total - Exercise/Conversion
Common Stock
2016-01-21+508→ 62,386 total
Footnotes (3)
- [F1]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted market stock units ("MSUs").
- [F2]Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index.
- [F3]The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.